Advanced search
Publication Cover
Cancer Investigation Volume 14, 1996 - Issue 6
Submit an article Journal homepage
3
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous Article

Autoimmune Phenomena in Patients Receiving Alpha-Interferon Therapy

Sevil E. Inanç Fellow, Medical Oncology, Institute of Oncology, University of Istanbul
,
Haluk Onat Professor, Medicai Oncology, Institute of Oncology, University of Istanbul
,
Harika Og˜uz Fellow, Endocrinology and Metabolism, Medical Faculty of Istanbul, Universiv of Istanbul
&
Erkan Topuz Professor and Chief, Medical Oncology, Director, Institute of Oncology, University of Istanbul
Pages 642-643 | Published online: 11 Jun 2009

References

  • Fentiman I S, Balkwill F R, Thomas B S, Russel M J, Todd I, Bottazzo G F. An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Eur J Cancer Clin Oncol 1988; 24: 1299–1303
  • Römiblom L E, Alm G V, öberg K E. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 115: 178–183
  • Sauter N P, Atkins M B, Mier J W, Lechan R M. Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-α therapy for melastatic carcinoma: A case report. Am J Med 1992; 92: 441–444
  • Burman P, Totterman T H, Oberg K, Karlsson F A. Thyroid autommunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab 1986; 63: 1086–1090
  • Pichert G, Jost L M, Zöbeli L, Odermatt B, Pedio G, Stahel R A. Thyroiditis after treatment with interleukin-2 and interferon α-2a. Br J Cancer 1990; 62: 100–104
  • Pangalis G A, Griva E. Recombinant alpha-2b-interferon therapy in untreated, stages A and B chronic lymphocytic leukemia. Cancer 1988; 61: 869–372
  • McLauglin P, Talpaz M, Qesada J R, Saleem A, Barlogie B, Gutterman J U. Immune thrombocytopenia following alpha-interferon therapy in patients with cancer. JAMA 1985; 254: 1333–1354
  • Rönnblom L E, öberg K E, Alm G V. Possible induction of systemic lupus erythematosus by interferon treatment in a patient with a malignant carcinoid tumor. Int J Med 1990; 227: 207–210
  • Schilling P J, Kurzrock R, Kantarjian H, Gutterman J U, Talpaz M. Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 1991; 68: 1536–1537
  • Baudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le Floch J P, Lemmonier C, Benhamou J P, Bok B. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol 1993; 39: 657–661

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.